A one-on-one conversation featuring Nobel Prize laureate Phillip Sharp and Endpoints News Editor-in-chief John Carroll.
Phillip A. Sharp
Institute Professor & Co-founder, Board Member, and Chair of Scientific Advisor Board MIT, Alnylam Pharmaceuticals
Founder & Editor Endpoints News
President Project Farma & Precision ADVANCE
Join John Carroll & Catalent’s Alessandro Maselli as they award the teams behind the winning companies and learn what defines the Endpoints 11.